Renaissance Capital logo

TYRA News

US IPO Weekly Recap: The Fall IPO market is in full swing with an 11 IPO week

TWKS

The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. Tech consultancy...read more

Oncology biotech Tyra Biosciences prices further upsized IPO at $16 high end

Tyra Biosciences logo

Tyra Biosciences, a preclinical biotech developing FGFR kinase inhibitors for solid tumors, raised $173 million by offering 10.8 million shares at $16, the high end of the range of $14 to $16. The company offered 1.8 million more shares than anticipated. It...read more

Oncology biotech Tyra Biosciences ups share offering by 34% ahead of $135 million IPO

Tyra Biosciences logo

Tyra Biosciences, a preclinical biotech developing FGFR kinase inhibitors for solid tumors, raised the proposed deal size for its upcoming IPO on Tuesday. The Carlsbad, CA-based company now plans to raise $135 million by offering 9 million shares at a price...read more

US IPO Week Ahead: The Fall IPO market kicks off with an 11 IPO week

TWKS

Updated Monday, 9/13. After a wave of launches in the short holiday week, 11 IPOs are scheduled to raise over $3 billion in the week ahead. Tech consultancy Thoughtworks (TWKS) plans to raise $700 million at a $6.3 billion market...read more